Showing results (131-140 of 291) with videos related to

Sort By:
Pageof 30
Blood Cells, Molecules & Diseases|November 6, 2004
Long-term outcome after haploidentical stem cell transplantation in childrenPeter Lang, Johann Greil, Peter Bader, et al.
Blood Cells, Molecules & Diseases|September 22, 2007
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patientsPeter Lang, Ingo Mueller, Johann Greil, et al.
Frontiers in Immunology|June 20, 2019
Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) CellsMelanie Bremm, Lisa-Marie Pfeffermann, Claudia Cappel, et al.
Blood Advances|February 3, 2026
Allogeneic HSCT for consolidation in pediatric refractory or relapsed ALK-positive anaplastic large cell lymphomaFabian Knörr, Martin Zimmermann, Peter Bader, et al.
International Journal of Cancer|June 3, 2016
Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survivalSarah Oelsner, Juliane Wagner, Miriam E Friede, et al.
Blood Advances|January 3, 2022
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysisFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
Frontiers in Immunology|December 19, 2019
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell TransplantationAnnekathrin Heinze, Beatrice Grebe, Melanie Bremm, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Will post-transplantation cell therapies for pediatric patients become standard of care?Arjan C Lankester, Franco Locatelli, Peter Bader, et al.
Molecular Therapy. Oncology|May 6, 2024
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulationCatrin Heim, Leonie Hartig, Nadine Weinelt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2018
Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP StudyIsaac Yaniv, Aviva C Krauss, Eric Beohou, et al.
Pageof 30